Germline Mutations and Phenotypic Associations in Korean Patients With Pheochromocytoma and Paraganglioma: A Multicenter Study and Literature Review
2024; 44(6): 591-597
Ann Lab Med 2016; 36(5): 475-480
Published online September 1, 2016 https://doi.org/10.3343/alm.2016.36.5.475
Copyright © Korean Society for Laboratory Medicine.
Jieun Kim, M.D.1, Chuhl Joo Lyu, M.D.2, Saeam Shin, M.D.3, Seung-Tae Lee, M.D.1, and Jong Rak Choi, M.D.1
Department of Laboratory Medicine1, Yonsei University College of Medicine, Seoul; Department of Pediatrics2, Yonsei Cancer Research Center, Yonsei University College of Medicine, Seoul; Department of Laboratory Medicine3, Hallym University College of Medicine, Kangnam Sacred Heart Hospital, Seoul, Korea
Correspondence to: Seung-Tae Lee
Department of Laboratory Medicine, Yonsei University College of Medicine, 50-1 Yonsei-ro, Seodaemun-gu, Seoul 03722, Korea
Tel: +82-2-2228-2450
Fax: +82-2-364-1583
E-mail: LEE.ST@yuhs.ac
Saeam Shin
Department of Laboratory Medicine, Hallym University College of Medicine, Kangnam Sacred Heart Hospital, 1 Singil-ro, Yeongdeungpo-gu, Seoul 07441, Korea
Tel: +82-2-829-5695
Fax: +82-2-847-2403
E-mail: ugine01@naver.com
Background: Intrachromosomal amplification of chromosome 21 (iAMP21) is known to be associated with poor prognosis in B-cell ALL (B-ALL). To determine the frequency and clinical characteristics of iAMP21 in Korean B-ALL patients, we performed FISH and multiplex ligation-dependent probe amplification (MLPA) analyses.
Methods: A total of 102 childhood B-ALL patients were screened with ETV6-RUNX1 FISH probes (Abbott Molecular, USA). The presence of an iAMP21 was confirmed by using MLPA P327 iAMP21-ERG probemix (MRC Holland, The Netherlands).
Results: iAMP21 was detected in one of the screened B-ALL patients (1/102 patients, 1.0%) who presented the ALL immunophenotype and complex karyotype at initial diagnosis. The patient relapsed twice after bone marrow transplantation. MLPA showed 12.5-Mb and 4.28-Mb regions of amplification and deletion, respectively.
Conclusions: The frequency of iAMP21 is considerable in Korean pediatric patients. Our report suggests that iAMP21 in childhood B-ALL has very unfavorable impact on patient’s prognosis. Additional methods such as MLPA analysis is essential to rule out patients with equivocal interphase FISH results.
Keywords: iAMP21, RUNX1, ERG, FISH, MLPA, Acute lymphoblastic leukemia, Korean, Childhood